Global Kinetics Secures FDA Clearance to Market Upgraded Wearable for PD Patients

(September 26, 2016) - The U.S. Food and Drug Administration gave a green light to Australian medtech business Global Kinetics, which sought 510(k) marketing clearance for the latest version of its Parkinson’s disease mobility tracker. The new device considerably extends the length of time patients can wear the KinetiGraph, a spokeswoman for the company said. Read more